Evidence map›Paper›PMID 28457472›Full record

ArticleAmerican journal of human genetics2017

Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families.

Thandiswa Ngcungcu, Martin Oti, Jan C Sitek, Bjørn I Haukanes, Bolan Linghu, Robert Bruccoleri, Tomasz Stokowy, Edward J Oakeley, Fan Yang, Jiang Zhu and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Chromatin Conformation in Development and Disease.Frontiers in cell and developmental biology · 2021
    Review
  8. Article
  9. Article
  10. Deficiency of the human cysteine protease inhibitor cystatin M/E causes hypotrichosis and dry skin.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Structural variation in the 3D genome.Nature reviews. Genetics · 2018
    Review
  15. Keratolytic Winter Erythema: An Update.Dermatopathology (Basel, Switzerland)
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 8 countries.

Thandiswa NgcungcuDivision of Human Genetics, School of Pathology and the Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
Martin OtiDepartment of Molecular Developmental Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6525 GA, the Netherlands; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Jan C SitekDepartment of Dermatology, Oslo University Hospital, Oslo 0424, Norway; Centre for Rare Disorders, Oslo University Hospital, Oslo 0424, Norway.
Bjørn I HaukanesCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway.
Bolan LinghuComputational Biomedicine, WRD Genome Sciences & Technologies, Pfizer Worldwide R&D, Cambridge, MA 02139, USA.
Robert BruccoleriNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA; Congenomics, Glastonbury, CT 06033, USA.
Tomasz StokowyDepartment of Clinical Science, University of Bergen, Bergen 5020, Norway.
Edward J OakeleyNovartis Institutes for BioMedical Research, Basel 4056, Switzerland.
Fan YangNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
Jiang ZhuNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
Marc SultanNovartis Institutes for BioMedical Research, Basel 4056, Switzerland.
Joost SchalkwijkDepartment of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Ivonne M J J van Vlijmen-WillemsDepartment of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Charlotte von der LippeCentre for Rare Disorders, Oslo University Hospital, Oslo 0424, Norway.
Han G BrunnerDepartment of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands; Maastricht UMC, Department of Clinical Genetics and School for Oncology and Developmental Biology (GROW), Maastricht 6202 AZ, the Netherlands.
Kari M ErslandCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway; Department of Clinical Science, University of Bergen, Bergen 5020, Norway.
Wayne GraysonSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand and Ampath National Laboratories, Johannesburg 2193, South Africa.
Stine Buechmann-MollerNovartis Institutes for BioMedical Research, Basel 4056, Switzerland.
Olav SundnesDepartment of Dermatology, Oslo University Hospital, Oslo 0424, Norway; Laboratory for Immunohistochemistry and Immunopathology, Department of Pathology, Oslo University Hospital, Oslo 0424, Norway.
Nanguneri NirmalaInstitute for Clinical Research and Policy Studies, Tufts University School of Medicine, Boston, MA 02111, USA.
Thomas M MorganNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
Hans van BokhovenDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Vidar M SteenCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway; Department of Clinical Science, University of Bergen, Bergen 5020, Norway.
Peter R HullDivision of Clinical Dermatology and Cutaneous Science, Dalhousie University, Halifax, NS B3H 1V7, Canada.
Joseph SzustakowskiTranslational Medicine, Bristol-Myers Squibb, Pennington, NJ 08534, USA.
Frank StaedtlerNovartis Institutes for BioMedical Research, Basel 4056, Switzerland.
Huiqing ZhouDepartment of Molecular Developmental Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6525 GA, the Netherlands; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Torunn FiskerstrandCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway; Department of Clinical Science, University of Bergen, Bergen 5020, Norway. Electronic address: torunn.fiskerstrand@helse-bergen.no.
Michele RamsayDivision of Human Genetics, School of Pathology and the Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa. Electronic address: michele.ramsay@wits.ac.za.
Radboud University Nijmegen · NLHaukeland University Hospital · NONovartis (Switzerland) · CHNovartis (United States) · USOslo University Hospital · NOUniversity of the Witwatersrand · ZABristol-Myers Squibb (United States) · USDalhousie University · CAPfizer (United States) · USTufts University · USUniversidade Federal do Rio de Janeiro · BRUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratolytic winter erythema (KWE) is a rare autosomal-dominant skin disorder characterized by recurrent episodes of palmoplantar erythema and epidermal peeling. KWE was previously mapped to 8p23.1-p22 (KWE critical region) in South African families. Using targeted resequencing of the KWE critical region in five South African families and SNP array and whole-genome sequencing in two Norwegian families, we identified two overlapping tandem duplications of 7.67 kb (South Africans) and 15.93 kb (Norwegians). The duplications segregated with the disease and were located upstream of CTSB, a gene encoding cathepsin B, a cysteine protease involved in keratinocyte homeostasis. Included in the 2.62 kb overlapping region of these duplications is an enhancer element that is active in epidermal keratinocytes. The activity of this enhancer correlated with CTSB expression in normal differentiating keratinocytes and other cell lines, but not with FDFT1 or NEIL2 expression. Gene expression (qPCR) analysis and immunohistochemistry of the palmar epidermis demonstrated significantly increased expression of CTSB, as well as stronger staining of cathepsin B in the stratum granulosum of affected individuals than in that of control individuals. Analysis of higher-order chromatin structure data and RNA polymerase II ChIA-PET data from MCF-7 cells did not suggest remote effects of the enhancer. In conclusion, KWE in South African and Norwegian families is caused by tandem duplications in a non-coding genomic region containing an active enhancer element for CTSB, resulting in upregulation of this gene in affected individuals.

Indexed as

Enhancer Elements, GeneticGene DuplicationGene Expression RegulationCase-Control StudiesCathepsin BChromosome MappingChromosomes, Human, Pair 8DNA-(Apurinic or Apyrimidinic Site) LyaseDNA Copy Number VariationsDNA GlycosylasesEpidermisEpigenomicsErythemaFemaleGenetic MarkersHumansCathepsin BCTSB protein, humanDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesGenetic MarkersNEIL2 protein, humanautosomal-dominant traitCTSBenhancer duplicationgene regulationkeratodermakeratolytic winter erythemaKWENorwaySouth Africatopological domains

Identifiers

PMID28457472
PMCPMC5420352
OpenAlexW2608952290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.